AMP 2026
The AMP Annual Meeting brings together the molecular pathology community to share advances, exchange ideas, and explore technologies shaping the future of diagnostics.
November 10-14, 2026
Seattle Convention Center, Seattle, WA
Meet our team at AMP 2026
Meet our team at Booth #1039
Meet our team at Booth #1039 to learn how Sampled’s capabilities can support your work.
Our multiomics experts will be on-site throughout the meeting to discuss emerging approaches, new applications, and the challenges shaping molecular pathology research today.
Service launch
Sampled Expands Oncology Portfolio with Two New Tumor Profiling Services
Sampled is introducing two new tumor profiling services designed to provide complementary DNA- and RNA-level insights into tumor biology. Together, they enable broader characterization of genomic variants, copy number changes, and oncogenic fusions across a wide range of tumor types.
DNA Comprehensive Tumor Profiling Service
Powered by the Twist CGP panel, this service provides targeted genomic profiling across 560 cancer-associated genes. The assay detects single nucleotide variants (SNVs), insertions and deletions (indels), copy number variants (CNVs), and select gene fusions across major tumor types.
RNA Fusion Tumor Profiling Service
Powered by the Twist Alliance CeGaT RNA Fusion panel, this service targets 160 genes across 30 cancer types and is designed for sensitive detection of both known and novel oncogenic fusions.
A More Complete View of Tumor Genomics
Used together, the two services combine DNA-level variant and copy number analysis with RNA-level fusion detection, providing a more comprehensive molecular view of each tumor and helping researchers capture alterations that may not be identified through a single profiling approach.
Visit Sampled at Booth #1039 at AMP 2026 to learn more, or schedule a meeting with our team using the form on this page.
Poster Presentation
Development and Validation of a High-Throughput CAP/CLIA-Compliant Laboratory-Developed Test for Comprehensive Genomic Profiling with Integrated RNA Fusion Detection Across Multiple Specimen Types
Presented By: Rwik Sen, PhD
Authors: Rwik Sen, PhD, Jonathan H. Schultz, PhD, Yan Ding, PhD, Michelle Carlson, PhD, Caroline Mitchell, PhD, Shareef Nahas, PhD
Friday, November 13th
9:15 AM – 10:15 AM
Exhibit & Poster Hall – Poster ST018
Category: Solid Tumors
Corporate Workshop
From Detection to Direction: Genomic Testing Strategies in Oncology Research
As genomic testing technologies mature across the oncology research and translational landscape, moving from assay validation to real-world application remains a critical area of focus. This session explores how next-generation sequencing tools are being leveraged in oncology-focused research, from initial validation through translational implementation, offering attendees practical insight into study design, evidence generation, and the path from research findings toward downstream clinical utility.
Hosted by: Twist Bioscience
Sampled Panelist: Jonathan H. Schultz, PhD
Wednesday, November 11th
1:00 PM – 1:50 PM
Chelan 2, Level 2, Arch at 800 Pike
Category: Solid Tumors
